Grand Rounds CAVERNOUS SINUS SYNDROME Denis Jusufbegovic, M.D. University of Louisville Department of Ophthalmology and Visual Sciences 01/04/13 Subjective CC: “ blurred vision OD x 1 month, double vision x 1-2 wks” HPI: 34 yo WM was referred to oculoplastics clinic on 09/25/12 for occasional double vision x 1-2 wks. Pt. also c/o of numbness around his R eye, intermittent headache and episodes of vomiting. Patient’s problems started on 08/28/12 after being splashed with power hose at work sustaining blunt trauma to R eye and face. He sought no medical attention. - He started developing ocular pain, photophobia, facial numbness and worsening vision OD few days after his injury. Was seen by local ophthalmologist on 09/07/12: Exam was significant for: BCVA OD 20/200 OS: 20/20 Slightly dilated min reactive pupil OD, no APD Full EOM OD: Eyelid edema, conj. injection, 4+cells/2+flare, no vitritis, retina flat Diagnosed with traumatic iritis, treated with PF q1-2 h 3 days follow up by local ophthalmologist on 09/10/12 showed: - improved BCVA OD 20/80 from 20/200 - OD: 2+cells, 2+flare, mutton-fat KPs - no other exam changes Diagnosis: Iritis OD Tx: Prednisone 80 mg PO to be tapered over 2 wks He returned to local ophthalmologist on 09/15/12 c/o “eye making popping sounds” Significant exam findings: BCVA OD 20/70 OS 20/20 No APD, full EOM “sunken eye socket OD” AC was deep and quiet OD Plan: complete PO Prednisone taper and obtain CT orbits 1st oculoplastics visit HPI: Pt. c/o intermittent binocular diplopia x 1-2 wks, photophobia OD, daily headaches assoc. with nausea/vomiting, numbness and tingling around R eye POH: unremarkable except recent injury PMH: negative FH: non-contributory All: NKDA MEDS: PredForte OD QID ROS: negative Objective 20/25 BCVA 20/20 P 4 2 3 2 O RAPD, brisk OU EOM: inconsistent mild -1 adduction deficit OD 12 T 13 Hertel: 10 100 12 External: partial numbness R V1 and V2, intact V3 Objective SLE: OD L/L C/S K AC I/L Vit OS normal OU clear OU clear OU 1+ c/f quiet faint pigment clear on ant. capsule no cells OU DFE: unremarkable except inf. temp PVD OD Imaging Single coronal CT face image demonstrates questionable small R orbital floor fracture and extensive pneumatization of sinuses of unknown significance Impression and Plan Resolving iritis OD, no obvious orbital fxs Observation, RTC in 2-3 weeks. Repeat CT scan if symptoms persist Follow up on 10/02/12 Pt. returned to clinic in 1 week c/o worsening diplopia, headaches, episodes of vomiting and facial numbness. He reported his R eye was “stuck”. No other complaints such as fever, chills, night sweats. BCVA 20/50 P 5 NR 3 2, brisk No RAPD External: pronounced decreased sensation R V1 and V2 and RUL ptosis with decreased LF of 4mm EOM: -3 limitation in all gaze directions OD; full OS SLE: unchanged 1+ c/f Impression Rapidly progressive R cranial nerve III, IV, V and VI palsy consistent with cavernous sinus process DDx: Inflammatory ( orbital pseudotumor, Talosa-Hunt syndrome, sarcoid, etc) Vascular (c-c fistula, cavernous sinus thrombosis) Neoplastic ( infiltration by hematologic or solid malignancies) Infectious (bacterial, fungal) Plan Urgent hospital admission MRI brain and orbits with gadolinium; MRA/MRV CXR Lab work:, CBC, CMP, ESR, CRP, ACE, c-ANCA, p-ANCA, RPR, quantiFERON-TB Results MRA/MRV: no C-C fistula, no aneurysm CXR: no hilar lymphadenopathy Lab work: negative MRI Coronal T1 MRI orbital/brain post contrast images show enhancement of R orbital soft tissue extending toward orbital apex, extensive pneumatization of sinuses and bilateral maxillary sinus disease MRI Axial T1 MRI orbital/brain post contrast images demonstrate R orbital soft tissue enhancement extending through orbital apex/superior orbital fissure to cavernous sinus. Soft tissue fullness R cavernous sinus, streaky enhancement of retrobulbar fat of both orbits R>L Impression/Plan Idiopathic inflammation possible Talosa-Hunt syndrome IV corticosteroids Discharged home on 2nd hospital day on Prednisone PO 80 mg daily Follow up on 10/09/12 Pt. continues to c/o binocular horizontal/vertical diplopia and headaches. BCVA Pupils: External: EOM: SLE: OD 20/100 OS 20/20 OD 5mm NR, OS 3mm reactive, no RAPD slightly improved R V1 and V2 sensation, improved ptosis OD slightly improved motility +0.5 cells/flare OD Image montage of five gaze positions demonstrates mild RUL ptosis and -2 limitation of extraocular motility in all gaze directions Impression/Plan Mild improvement of R cavernous sinus syndrome on high dose corticosteroids Clinical presentation concerning for R cavernous sinus carcinomatosis Corticosteroid taper, neuro-ophth and neurosurgery consult Neuro-ophth evaluation Pt. was seen in neuro-ophthalmology clinic within one week. He reported no improvements in his symptoms Corticosteroids were slowly tapered Given response to corticosteroids and lesion location, biopsy was postponed at this time Over the next four weeks pt. reported slight improvement in his diplopia. However, he c/o headache, nausea, occasional vomiting, loss of appetite, 15 lbs. weight loss x 3 weeks Turn for the worse Pt. presented to ER on 11/24/12 with dyspnea at rest, body aches, dry cough, fevers x 1 week CBC showed pancytopenia: wbc 1.97, Hgb 8.6, plts 12K CT chest showed diffuse ground glass opacities and left pleural effusion Pt. was admitted and started on broad spectrum abx, underwent thoracentesis with 1L bloody exudate and bone marrow biopsy Hospital Course Pt. continued to worsen and was transferred to ICU for acute respiratory distress syndrome (ARDS) and multi system failure He expired in early December 2012 Final Diagnosis Thoracentesis fluid flow cytometry analysis showed monoclonal CD3-/CD4-/CD8-/CD16-/CD 56+ lymphocytes Bone marrow biopsy confirmed the same results These findings are consistent with: Natural killer T cell lymphoma Discussion Lymphoma of the Ocular Adnexa 1%-2% of all lymphomas and 8% of extranodal lymphomas arise in the ocular adnexa 10%-20% of orbital mass lesions are found to be lymphoid tumors Lymphomas are the most common orbital malignancy Ferry JA, Fung CY, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007 Feb;31(2):170-84. Lymphoma of the Ocular Adnexa Most lymphomas arising in the ocular adnexa are low-grade B-cell lymphomas SYSTEMIC OCULAR ADNEXAL LYMPHOMA (OAL),n=353 Diffuse large B-cell 30.6% MALT 52% Follicular 22.1% Follicular 23% MALT 7.6% Diffuse large B-cell 8% CLL 6.7% Mantle Cell 5% Mantle Cell 6.0% CLL 4% Ferry JA, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007 Feb;31(2):170-84. Harris NL, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J. 2000;1(1):53-66 Natural Killer T (NK/T)-cell lymphoma NK/T-cell lymphoma, known as "lethal midline granuloma“, is a rare disorder in the US Type of extranodal lymphoma most commonly originating from nasal passages and paranasal sinuses More prevalent in Asia and South America where it comprises 5% of all non-Hodgkin lymphomas. Avg age at presentation is 52 yrs Virtually all cases contain monoclonal episomal EBV DNA Kanavaros P, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81(10):2688. Jaffe ES, et al.. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20(1):103. Ocular complications of NK/Tcell lymphoma Primary orbital/ocular NK/T lymphoma is a very rare condition with only 8 cases reported Orbital/ocular involvement is most commonly an extension of nasal and paranasal sinus disease Vision-threatening complications stem from orbital inflammation or uveitis/vitritis Ely A, et al. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature. Orbit. 2012 Aug;31(4):267-9. Ocular complications Hon et al retrospectively studied records of 35 consecutive patients with NK/T lymphoma between 1996-2000 24 pts had primary nasal/sinus disease 6 out of 24 pts (25%) developed ocular complications: 3 pts had orbital infiltration only 1 pts with orbital infiltration and uveitis/vitritis 2 pt with uveitis/vitritis only Intraocular involvement such as uveitis and vitritis is an important feature predicting high probability of leptomeningeal or CNS involvement Hon et al. Vision-threatening Complications of Nasal T/NK Lymphoma. American Journal of Ophthalmology 2002; 134 (3): 407-410. Prognosis Extranodal NK/T cell lymphoma is a very aggressive disease Patients with extranasal disease have median survival of 4 months Thank you References 1. 2. 3. 4. 5. 6. 7. 8. Ely A, Evans J, Sundstrom JM, Malysz J, Specht CS, Wilkinson M. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature. Orbit. 2012 Aug;31(4):267-9. Ferry JA, Fung CY, Zukerberg L, Lucarelli MJ, Hasserjian RP, Preffer FI, Harris NL. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007 Feb;31(2):170-84. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J. 2000;1(1):53-66 Hon et al. Vision-threatening Complications of Nasal T/NK Lymphoma. American Journal of Ophthalmology 2002; 134 (3): 407-410. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20(1):103. Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008 Jun;145(6):941-50. Kanavaros P, Lescs MC, Brière J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81(10):2688. Woog JJ, Kim YD, Yeatts RP, Kim S, Esmaeli B, Kikkawa D, Lee HB, Korn BS, Punja K, Habermann TM, Colgan JP, Salomao D, Cameron JD. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006 Jan;113(1):140-7